Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

NCT00189800 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00189800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder